3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 1
2
Phase 2
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Gastrointestinal
2
Breast
2
Other hematologic neoplasm
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Conditions
Carcinoma, Non-Small-Cell Lung
1228
Lung Neoplasms
560
Colorectal Neoplasms
282
Breast Neoplasms
257
Neoplasms
254
Melanoma
236
Small Cell Lung Carcinoma
234
Ovarian Neoplasms
234
Pancreatic Neoplasms
186
Squamous Cell Carcinoma of Head and Neck
171
Neoplasm Metastasis
171
Carcinoma, Renal Cell
164
Stomach Neoplasms
158
Triple Negative Breast Neoplasms
127
Head and Neck Neoplasms
121
Esophageal Neoplasms
115
Prostatic Neoplasms
106
Urinary Bladder Neoplasms
105
Colonic Neoplasms
95
Uterine Cervical Neoplasms
93
Endometrial Neoplasms
93
Mesothelioma
84
Mesothelioma, Malignant
79
Carcinoma, Hepatocellular
78
Sarcoma
70
Carcinoma, Transitional Cell
69
Kidney Neoplasms
65
Carcinoma, Ovarian Epithelial
50
Adenocarcinoma of Lung
47
Rectal Neoplasms
45
Interventions
palbociclib
2
Rivaroxaban
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1
×
Inflammation
×
Thoracic
×
Clear all
NCT06307249
2024-03-12
PTST_PALBEVA
Lebanese University
Phase 1
Recruiting
50 enrolled
NCT06065592
2023-10-06
CAT_PB
Lebanese University
Phase 1
Unknown
500 enrolled